07:00 , Aug 11, 2014 |  BC Week In Review  |  Clinical News

AmpliVue GAS Assay regulatory update

FDA granted 510(k) clearance to Quidel’s AmpliVue GAS Assay to qualitatively detect Group A beta-hemolytic Streptococcus pyogenes nucleic acids isolated from throat swab specimens from patients with signs and symptoms of pharyngitis. The hand-held assay...